Search

everythinglearnresearchcommunity

for

Search:↓

The FUE-LE technique combines two hair transplant methods to harvest more hair with minimal visible scarring, especially for patients with advanced hair loss.

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

Increased liposome fluidity boosts skin penetration of sodium fluorescein.

There is a significant need for better-validated quality of life tools in dermatology.

A risk prediction model can help diagnose systemic lupus erythematosus earlier in primary care.

Low-level laser therapy seems to promote hair growth but requires more research to confirm its effectiveness.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Low-level red light therapy can shorten eye length in some myopic children.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

LSD1 and HSP90 help heal skin wounds by changing hair follicle stem cells' metabolism.

A unique type of lupus panniculitis causes reversible hair loss on the scalp in East Asians.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Basement membrane changes in lichen planopilaris cause scarring and permanent hair loss.

Acyclovir can prevent rejection of skin grafts in herpes-related lip leucoderma.

DNA methylation likely doesn't cause different lambskin patterns in Hu sheep.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

The document's content could not be processed.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Dermatologists should recognize diverse discoid lupus signs to avoid misdiagnosis.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Tinea faciale can be mistaken for lupus due to similar symptoms.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

The document's conclusion cannot be summarized because the content is not understandable.